Iftikhar, Imran H. http://orcid.org/0000-0001-5102-5193
Cistulli, Peter A.
Jahrami, Haitham
Alamoud, Khalid A.
Saeed, Maarij
Soulimiotis, Andrew P.
BaHammam, Ahmed S.
Article History
Received: 8 August 2022
Revised: 25 October 2022
Accepted: 5 November 2022
First Online: 14 November 2022
Declarations
:
: Not required.
: Not required.
: IHI, ASB, JH, MS, AS, and KA have nothing to disclose. PAC has an appointment to an endowed academic Chair at the University of Sydney that was created from ResMed funding. He has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/adviser to ResMed, SomnoMed, and Signifier Medical Technologies. He has a pecuniary interest in SomnoMed related to a previous role in R&D (2004). This study was not sponsored by any funding agency or pharmaceutical company.